Clinical Evolution and Becoming of Adult Patients Infected With Covid-19 Hospitalized at Strasbourg University Hospitals

NCT04706260 | Completed

• 1 other identifier: 7839
• Study Type: observational
• Target: 600
• Locations: 1 country
• Sites: 1

Brief Summary

A SARS-CoV-2 infection emerged in China in December 2019, the severity of which is linked to acute respiratory distress syndrome1. The rate of emergency visits in Bas-Rhin for suspected Covid-19 increased, compared to the French average, at the end of the 10th week of 2020. Compared to the onset of symptoms, Chinese studies estimate the onset of dyspnea on the 7th day3 and admission to the emergency room between the 5th and the 9th day4. But this duration varies according to the epidemic period5, the geographical location6 and a later emergency admission is associated with an increase in mortality in the Chinese population7. The need for oxygen, which is not noted in Chinese studies8, is a reflection of the onset of respiratory worsening and a major factor in hospitalization. There is no study on the changing profile of the French population to date its onset.

Conditions

Covid-19

Keywords

COVID-19; COVID-19 Pandemic; Sars-cov-2; Emergency Department

Outcome Measures

Primary Outcomes (1)

• Retrospective evaluation of the clinical evolution and becoming of adult patients infected with Covid-19 hospitalized at the University Hospitals of Strasbourg from the Emergency Structure

  Files analysed retrospectily from March 06, 2020 to April 05, 2020 will be examined]

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult patient with covid-19 hospitalized at HUS between 06/03/2020 and 05/04/2020.

You may qualify if:

• Male or female aged 18 or over
• Admitted to the NHC emergency room and hospitalized at the Strasbourg University Hospitals (HUS) between 06/03/2020 and 05/04/2020.
• With SARS-CoV-2 RT-PCR on a positive nasopharyngeal sample taken at the SU.

You may not qualify if:

• Refusal to participate in the study
• Return home from the SU
• Transfer to another establishment
• Patient under the protection of justice
• Patient under guardianship, curatorship

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Adult Emergency Department - Strasbourg University Hospitals

Strasbourg, 67091, France

Location

MeSH Terms

Conditions

COVID-19; Emergencies

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Mathieu OBERLIN, MD

  Adult Emergency Department - Strasbourg University Hospitals

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 8, 2021
• First Posted: January 12, 2021
• Study Start: April 14, 2020
• Primary Completion: April 14, 2021
• Study Completion: April 14, 2021
• Last Updated: October 7, 2021

Record last verified: 2021-01

Locations

FR (1)